ARRAKIS THERAPEUTICS INC has a total of 26 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are CHDI FOUNDATION INC, GHOSH ARUN K and SINT QUIMICA SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | Canada | 3 | |
#4 | China | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Singapore | 3 | |
#7 | United States | 3 | |
#8 | Israel | 2 | |
#9 | Mexico | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology | |
#4 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Barsoum James Gregory | 14 |
#2 | Kumaravel Gnanasambandam | 14 |
#3 | Petter Russell C | 13 |
#4 | Kubica Neil | 12 |
#5 | Petter Jennifer C | 8 |
#6 | Blain Jonathan Craig | 8 |
#7 | Bair Kenneth W | 7 |
#8 | Fang Chao | 7 |
#9 | Chin Donovan Noel | 7 |
#10 | Mukherjee Herschel | 7 |
Publication | Filing date | Title |
---|---|---|
WO2019236644A1 | Encoded libraries and methods of use for screening nucleic acid targets | |
CN111386127A | Nucleic acid-binding light probes and uses thereof | |
WO2018006074A2 | Compounds and methods for modulating rna function | |
MX2018009325A | Compounds and methods of treating rna-mediated diseases. |